Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-12-16
pubmed:abstractText
Nevirapine is widely used in the developing world for the prevention of mother-to-child transmission (PMTCT) of HIV. A single mutation in the HIV genome is sufficient to lead to significant nevirapine resistance. Persistence of low-level drug concentrations in body compartments can foster resistance formation. In this study, concentration-time courses of nevirapine after single-dose administration were analysed over an extended post-partum period.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1460-2091
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
170-7
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Persistence of nevirapine in breast milk and plasma of mothers and their children after single-dose administration.
pubmed:affiliation
Institute of Tropical Medicine and International Health, Charité-University Medicine Berlin, Berlin, Germany. andrea-ursula.kunz@charite.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't